Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study. / Bretler, Ditte-Marie; Hansen, Peter Riis; Abildstrøm, Steen Zabell; Jørgensen, Casper Haslund; Sørensen, Rikke; Hansen, Morten Lock; Schramm, Tina Ken; Løkkegaard, Ellen; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Jørgensen, Casper Haslund.
I: British Journal of Clinical Pharmacology, Bind 71, Nr. 1, 01.01.2011, s. 105-15.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study
AU - Bretler, Ditte-Marie
AU - Hansen, Peter Riis
AU - Abildstrøm, Steen Zabell
AU - Jørgensen, Casper Haslund
AU - Sørensen, Rikke
AU - Hansen, Morten Lock
AU - Schramm, Tina Ken
AU - Løkkegaard, Ellen
AU - Torp-Pedersen, Christian
AU - Gislason, Gunnar Hilmar
AU - Jørgensen, Casper Haslund
N1 - © 2010 The Authors. British Journal of Clinical Pharmacology © 2010 The British Pharmacological Society.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: General use of hormone replacement therapy (HRT) dropped drastically after 2002 when pivotal randomized trials showed increased risk of coronary artery disease and other complications with HRT. HRT is not recommended for primary or secondary prevention of coronary heart disease and guidelines recommend discontinuation of HRT after myocardial infarction (MI). It is unknown whether women actually discontinue HRT after MI.
AB - WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: General use of hormone replacement therapy (HRT) dropped drastically after 2002 when pivotal randomized trials showed increased risk of coronary artery disease and other complications with HRT. HRT is not recommended for primary or secondary prevention of coronary heart disease and guidelines recommend discontinuation of HRT after myocardial infarction (MI). It is unknown whether women actually discontinue HRT after MI.
U2 - 10.1111/j.1365-2125.2010.03790.x
DO - 10.1111/j.1365-2125.2010.03790.x
M3 - Journal article
C2 - 21143506
VL - 71
SP - 105
EP - 115
JO - British Journal of Clinical Pharmacology, Supplement
JF - British Journal of Clinical Pharmacology, Supplement
SN - 0264-3774
IS - 1
ER -
ID: 34044241